Related Experiment Video

Updated: Aug 9, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction

Jose Martinez-Ojeda1, Jose Martinez-Toro

  • 1Cadiology Fellow, University Hospital, University of Puerto Rico, School of Medicine, San Juan. josemartinez00@hotmail.com

Boletin De La Asociacion Medica De Puerto Rico
|April 8, 2006
PubMed

Insights

ST elevation myocardial infarction management has evolved. Percutaneous coronary intervention, with advanced therapies, shows benefits over fibrinolysis in reducing heart attack severity and mortality.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • ST elevation myocardial infarction (STEMI) management has seen significant advancements.
  • Fibrinolytic agents have improved clot specificity and efficacy.
  • Percutaneous coronary intervention (PCI) with adjuvant therapies has emerged as a key treatment.

Purpose of the Study:

  • To compare the efficacy of PCI versus fibrinolysis in managing STEMI.
  • To evaluate the impact of PCI on infarct size, myocardial function, and mortality.

Main Methods:

  • Review of studies comparing PCI and fibrinolysis for STEMI.
  • Analysis of outcomes including infarct size, left ventricular function, and mortality rates.

Main Results:

  • PCI, particularly with glycoprotein IIB/IIIA inhibitors and clopidogrel, challenges traditional fibrinolytic therapy.
  • Studies demonstrate superior outcomes with PCI compared to fibrinolysis in STEMI management.
  • PCI leads to decreased infarct size, improved myocardial function, and reduced mortality.

Conclusions:

  • Percutaneous coronary intervention is a highly effective treatment for ST elevation myocardial infarction.
  • PCI offers significant advantages over fibrinolysis in improving patient outcomes and reducing mortality in STEMI.
  • The combination of PCI and adjuvant therapies represents a paradigm shift in STEMI care.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...